A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Abemaciclib D5 | CAS 1809251-51-1 - Request Quote

Picture of Abemaciclib D5

Abemaciclib D5

SZ CAT No:SZ-A077D03
CAS No
1809251-51-1
Mol.F.
C27H27D5F2N8
Mol.Wt.
511.6
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Abemaciclib D5 is chemically N-(5-((4-(Ethyl-d5)piperazin-1-yl)methyl)pyridin-2-yl)-5-fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazol-6-yl)pyrimidin-2-amine. Abemaciclib D5 is supplied with detailed characterization data compliant with regulatory guideline. Abemaciclib D5 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Abemaciclib.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 1809251-51-1

Purchase 1809251-51-1

Order 1809251-51-1

Enquire 1809251-51-1

price of 1809251-51-1

1809251-51-1 Supplier

1809251-51-1 Manufacturer

1809251-51-1 Exporter

buy high quality Abemaciclib D5

Purchase Abemaciclib D5

Abemaciclib D5 suppliers

Abemaciclib D5 manufacturers

Abemaciclib D5 price

Order Abemaciclib D5

Enquire Abemaciclib D5

Abemaciclib D5 cost

Abemaciclib D5 Supplier

Abemaciclib D5 Distributor

Abemaciclib D5 for Method Validation

Abemaciclib Reference Standard

Abemaciclib D5 for ANDA Filing

Abemaciclib D5 for Forced Degradation Studies

Abemaciclib D5 Identification Standards

Abemaciclib D5 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,